Canada’s Leading Pricing and Reimbursement Consultancy
Established in 1996, PDCI Market Access is Canada’s leading pricing and reimbursement consultancy. PDCI features over twenty staff, including experienced bilingual consultants and analysts. Headquartered in Ottawa, PDCI also has several consultants based in the Toronto area.
PDCI prides itself on being the only Canadian consultancy with core competencies and expertise in both pricing and reimbursement. We are a client focused, mid-size consultancy large enough to address any contingencies, but small enough that senior staff work directly with our clients on all projects. PDCI has significant support infrastructure, including claims and price databases, scientific resources, and market intelligence.
We help Pharma/Biotech firms:
PDCI’s Projects Include:
Roubaix Strategies Inc. delivers an essential suite of services that will make a difference in gaining the best possible market access:
PIVINA Consulting Inc. is an innovative and energetic company with core capabilities in market access, reimbursement strategies, and health economic evaluations with extensive submission experience to public and private payers, such as the CDR, pCODR, and INESSS. PIVINA’s experience also includes developing and implementing overall clinical and economic strategies for these products AND additional analytical capabilities in support of reimbursement. Further, PIVINA has had the opportunity to work on numerous product listing agreements and have worked on ~20 products that have either gone through pCPA or are currently under pCPA review; thus, provide clients with added value and support through this new process.
QuintilesIMS (QI) is a leading global healthcare provider of integrated information and technology-enabled services. QI is dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QI’s approximately 50,000 employees conduct operations in more than 100 countries. QI develops and implements solutions to help its clients maximize innovation and drive healthcare forward.
Innomar Strategies, part of AmerisourceBergen, is the leading service provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Innomar’s integrated services include:
• Consulting services
• Patient support programs
• Nursing and clinical services
• Specialty pharmacy and logistics
We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to patient care, Innomar Strategies helps manufacturers optimize product performance in the complex Canadian healthcare environment.
Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the health care industry to provide patients with better, safer care. The company’s solutions empower pharmacies, manufacturers, hospitals and other health care institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada.
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.
STI Technologies Limited, a QuintilesIMS company, is a healthcare technology company that manages patient support programs. It improves access to medications by leveraging available reimbursement funding and innovative technology to engage patients in their own healthcare.
Today, STI’s extensive technological expertise and resources power three lines of business:
Reach, powered by STI, enhances patient choice and access to the best in pharmaceuticals throughout the product lifecycle by delivering intelligent reimbursement solutions while leveraging technology to improve patient engagement and health outcomes.
Assist, powered by STI, redefines patient assistance and support, helping patients and healthcare professionals access your medications with unprecedented speed, efficiency, and empathy.
Discover, powered by STI, provides new depths in de-identified patient data and insight, furthering your business while helping you improve patient journeys.